All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Antineoplastic agents

Lazcluze

(lazertinib)

Uses, side effects, dosage information & price range

Janssen Cilag International NV

About this medicine

Lazcluze in combination with amivantamab is indicated for the first line treatment of adult patients with advanced non small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 L858R substitution mutations.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

PoherdyComposition: pertuzumabOrganon N.V.
Price on RequestView Details →
MekinistComposition: trametinibNovartis Europharm Limited
Price on RequestView Details →
VijoiceComposition: alpelisibNovartis Europharm Limited
Price on RequestView Details →
KisqaliComposition: ribociclibNovartis Europharm Limited
Price on RequestView Details →
TecartusComposition: brexucabtagene autoleucelKite Pharma EU B.V.
Price on RequestView Details →

Key Information

Salt / Composition

lazertinib

Category

Antineoplastic agents

Manufacturer

Janssen Cilag International NV

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.